{"id":"https://openalex.org/W2008733255","doi":"https://doi.org/10.1111/j.2042-7158.1995.tb06740.x","title":"Pharmacological Properties of 403U76, a New Chemical Class of 5-Hydroxytryptamine- and Noradrenaline-reuptake Inhibitor","display_name":"Pharmacological Properties of 403U76, a New Chemical Class of 5-Hydroxytryptamine- and Noradrenaline-reuptake Inhibitor","publication_year":1995,"publication_date":"1995-09-01","ids":{"openalex":"https://openalex.org/W2008733255","doi":"https://doi.org/10.1111/j.2042-7158.1995.tb06740.x","mag":"2008733255","pmid":"https://pubmed.ncbi.nlm.nih.gov/8583392"},"language":"en","primary_location":{"id":"doi:10.1111/j.2042-7158.1995.tb06740.x","doi":"https://doi.org/10.1111/j.2042-7158.1995.tb06740.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1995.tb06740.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108196292","display_name":"Robert M. Ferris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87048295","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"R M Ferris","raw_affiliation_strings":["The Wellcome Research Laboratories, Department of Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wellcome Research Laboratories, Department of Pharmacology","institution_ids":["https://openalex.org/I87048295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110623287","display_name":"Lawrence E. Brieaddy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Brieaddy","raw_affiliation_strings":["Organic Chemistry , Research Triangle Park, NC 27709,","Organic Chemistry, Research Triangle Park, NC 27709, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organic Chemistry , Research Triangle Park, NC 27709,","institution_ids":[]},{"raw_affiliation_string":"Organic Chemistry, Research Triangle Park, NC 27709, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046703350","display_name":"Nariman B. Mehta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87048295","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N Mehta","raw_affiliation_strings":["The Wellcome Research Laboratories, Department of Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wellcome Research Laboratories, Department of Pharmacology","institution_ids":["https://openalex.org/I87048295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008762444","display_name":"Elizabeth B. Hollingsworth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87048295","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E Hollingsworth","raw_affiliation_strings":["The Wellcome Research Laboratories, Department of Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wellcome Research Laboratories, Department of Pharmacology","institution_ids":["https://openalex.org/I87048295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086351035","display_name":"Greg C. Rigdon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87048295","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G Rigdon","raw_affiliation_strings":["The Wellcome Research Laboratories, Department of Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wellcome Research Laboratories, Department of Pharmacology","institution_ids":["https://openalex.org/I87048295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052563732","display_name":"C Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87048295","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C Wang","raw_affiliation_strings":["The Wellcome Research Laboratories, Department of Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wellcome Research Laboratories, Department of Pharmacology","institution_ids":["https://openalex.org/I87048295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111621318","display_name":"Francis E. Soroko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87048295","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"F Soroko","raw_affiliation_strings":["The Wellcome Research Laboratories, Department of Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wellcome Research Laboratories, Department of Pharmacology","institution_ids":["https://openalex.org/I87048295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111801542","display_name":"William B. Wastila","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87048295","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"W Wastila","raw_affiliation_strings":["The Wellcome Research Laboratories, Department of Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wellcome Research Laboratories, Department of Pharmacology","institution_ids":["https://openalex.org/I87048295"]}]},{"author_position":"last","author":{"id":null,"display_name":"B Cooper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87048295","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I87048295"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"B Cooper","raw_affiliation_strings":["The Wellcome Research Laboratories, Department of Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Wellcome Research Laboratories, Department of Pharmacology","institution_ids":["https://openalex.org/I87048295"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5108196292"],"corresponding_institution_ids":["https://openalex.org/I87048295"],"apc_list":{"value":2911,"currency":"GBP","value_usd":3839},"apc_paid":null,"fwci":0.1193,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.30626384,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"47","issue":"9","first_page":"775","last_page":"781"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.836899995803833,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.836899995803833,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0957999974489212,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.05730000138282776,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/norepinephrine-reuptake-inhibitors","display_name":"norepinephrine reuptake inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/serotonin-norepinephrine-reuptake-inhibitors","display_name":"serotonin-norepinephrine reuptake inhibitors","score":0.7369999885559082},{"id":"https://openalex.org/keywords/serotonin-uptake","display_name":"serotonin uptake","score":0.5619999766349792},{"id":"https://openalex.org/keywords/norepinephrine-uptake","display_name":"norepinephrine uptake","score":0.8730000257492065},{"id":"https://openalex.org/keywords/dorsal-raphe-neurons","display_name":"dorsal raphe neurons","score":0.8119999766349792},{"id":"https://openalex.org/keywords/serotonin-depletion","display_name":"serotonin depletion","score":0.7860000133514404},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.925000011920929},{"id":"https://openalex.org/keywords/antidepressant-potential","display_name":"antidepressant potential","score":0.777999997138977},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.5690000057220459},{"id":"https://openalex.org/keywords/synaptosomes","display_name":"synaptosomes","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7548084259033203},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.5975654721260071},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5878903865814209},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.582624614238739},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5735223293304443},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5276169776916504},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.47839152812957764},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.44056209921836853},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.42903172969818115},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29866793751716614},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2784939408302307},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27231699228286743},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15128758549690247},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.10983419418334961},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09251448512077332},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000831","descriptor_name":"Animals, Newborn","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001592","descriptor_name":"Benzyl Alcohols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001592","descriptor_name":"Benzyl Alcohols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004594","descriptor_name":"Electrophysiology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006916","descriptor_name":"5-Hydroxytryptophan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006916","descriptor_name":"5-Hydroxytryptophan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011903","descriptor_name":"Raphe Nuclei","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011903","descriptor_name":"Raphe Nuclei","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013747","descriptor_name":"Tetrabenazine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013747","descriptor_name":"Tetrabenazine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D013747","descriptor_name":"Tetrabenazine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014828","descriptor_name":"Vocalization, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.2042-7158.1995.tb06740.x","doi":"https://doi.org/10.1111/j.2042-7158.1995.tb06740.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1995.tb06740.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:8583392","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8583392","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1963895082","https://openalex.org/W1970364046","https://openalex.org/W1977829278","https://openalex.org/W1983223101","https://openalex.org/W1989582849","https://openalex.org/W1992885869","https://openalex.org/W1995127336","https://openalex.org/W2002890068","https://openalex.org/W2005673642","https://openalex.org/W2018402097","https://openalex.org/W2025564011","https://openalex.org/W2035677820","https://openalex.org/W2043750066","https://openalex.org/W2062815987","https://openalex.org/W2066163123","https://openalex.org/W2066462196","https://openalex.org/W2069027411","https://openalex.org/W2072219714","https://openalex.org/W2077760177","https://openalex.org/W2081494794","https://openalex.org/W2088116769","https://openalex.org/W2095356255","https://openalex.org/W2123353332","https://openalex.org/W2144886680","https://openalex.org/W2255064238","https://openalex.org/W2401188729","https://openalex.org/W4406968683","https://openalex.org/W6667414576"],"related_works":["https://openalex.org/W2409316332","https://openalex.org/W2002669946","https://openalex.org/W2033369940","https://openalex.org/W2276059445","https://openalex.org/W2135557968","https://openalex.org/W2015754873","https://openalex.org/W2071957788","https://openalex.org/W2315573839","https://openalex.org/W2008150716","https://openalex.org/W2077640214"],"abstract_inverted_index":{"403U76":[0,25,67,77,97,119,125,163],"(5-chloro-[[2-[(dimethylamino)methyl]phenyl]thio]benzene-":[1],"methanol":[2],"hydrochloride)":[3],"is":[4,172],"a":[5,73,167,173],"potent,":[6,174],"competitive,":[7],"inhibitor":[8,176],"of":[9,20,30,34,42,45,51,63,66,86,93,124,177],"5-hydroxytryptamine":[10],"(5-HT)":[11],"and":[12,38,40,129,158,179],"noradenaline":[13],"reuptake":[14],"into":[15],"rat":[16],"brain":[17],"synaptosomes.":[18],"Inhibition":[19],"5-HT":[21,46,74,94,178],"uptake":[22,75],"in-vivo":[23],"by":[24,28,111],"was":[26,58,109],"demonstrated":[27],"potentiation":[29],"the":[31],"behavioural":[32,139],"effects":[33],"5-hydroxytryptophan":[35],"in":[36,47,56,113,116],"rats":[37,57],"mice":[39],"blockade":[41],"p-induced":[43],"depletion":[44],"rats.":[48],"The":[49],"firing":[50],"5-HT-ergic":[52,103],"dorsal":[53],"raphe":[54],"neurons":[55],"decreased":[59],"after":[60,118],"intravenous":[61,122],"administration":[62],"low":[64],"doses":[65,123],"as":[68,100,102],"would":[69],"be":[70,165],"predicted":[71],"for":[72],"inhibitor.":[76],"antagonized":[78],"tetrabenazine-induced":[79],"sedation,":[80],"an":[81],"effect":[82],"associated":[83],"with":[84,91],"inhibitors":[85,92],"noradrenaline":[87,180],"uptake,":[88],"but":[89],"not":[90],"uptake.":[95],"Thus":[96,162],"affects":[98],"noradrenergic":[99],"well":[101,127],"neurotransmission":[104],"in-vivo.":[105],"Potential":[106],"anxiolytic":[107],"activity":[108],"indicated":[110],"reductions":[112],"isolation-induced":[114],"vocalizations":[115],"neonates":[117],"treatment.":[120],"Low":[121],"were":[126,136,159],"tolerated":[128],"had":[130],"no":[131,137],"sustained":[132],"cardiovascular":[133],"effects.":[134],"There":[135],"deleterious":[138],"side-effects":[140],"at":[141,154],"active":[142],"doses.":[143],"Effects":[144],"observed":[145],"on":[146],"isolated":[147],"tissues":[148],"or":[149],"transmitter":[150],"receptors":[151],"occurred":[152],"only":[153],"very":[155],"high":[156],"concentrations":[157],"pharmacologically":[160],"unimportant.":[161],"can":[164],"considered":[166],"potential":[168],"antidepressant/anxiolytic":[169],"agent":[170],"that":[171],"selective":[175],"reuptake.":[181]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}